Barely Significant
← all phrases

“borderline significant”

11,410 sentences · 11,410 papers · 14,072 search hits before verification · confirmed specimen

Sighted at

p=0.09

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

borderline significantP = 0.0751.5× alphagold
Similarly, antibody levels against each of the Pmp subtypes were not significantly associated with PID, although the response to H-rPmpI was borderline significant (Fig. 2 ; OR: 2.52, 95% CI: 0.89–7.11, P = 0.075/first vs. second tertile).
borderline significantP = 0.0751.5× alphagold
We cannot fully explain the delayed plasma increase of creatinine, and the lack of an immediate post-exercise increase – even though borderline significant ( P = 0.075)—is in contrast to results from previous studies in runners completing a marathon race (McCullough et al., 2011 ; Trivax et al., 2010 ) or to runners completing a 100 km race (Kao et al., in press ).
borderline significantp = 0.0751.5× alphagold
Younger respondents (<60 years) reported a significantly higher burden for bother with medication side effects and for diet (p < .05); they also reported a higher burden for medical appointments, which was borderline significant (p = 0.075).
borderline significantp = 0.0751.5× alphagold
CA models indicating that veteran wives had fewer depressive symptoms than non-veteran wives were borderline significant (β = -0.41, 95%CI: (-0.87, 0.04), p = 0.075); there no difference in number of depressive symptoms between veteran and non-veteran wives in either subgroup, though all point estimates were in the same direction.
borderline significantP = 0.07581.5× alphagold
A borderline significant association with shorter PFI was observed for stage IVa versus IIIc cancer (HR = 3.19, 95% CI = 0.89–11.46, P = 0.0758), whereas an opposite trend was found for higher total CD8 + TIL count (HR = 0.67, 95% CI = 0.41–1.09, P = 0.1040) and SLFN11 H-score assessed in cancer cells only (HR = 0.62, 95% CI = 0.38–1.02, P = 0.0620).
borderline significantp = 0.0761.5× alphagold
Although sexual stage antibody prevalence was least common in those who did not develop gametocytes during follow-up (p<0.001), there was a borderline significant increase in the prevalence of both Pfs230 (p = 0.076) and Pfs48/45 antibodies (p = 0.14) between day 7, 28, and 84 in this group.